Institutional Ownership
Barinthus Biotherapeutics Pl
CUSIP 91864C107ADSBRNSQ1 2026
13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
25.2%
Max % of class reported
Institutional Holders
14
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
10 filings · latest Feb 11, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 11, 2025 | Frank W. Cawood | 13G/A | 8.4% | 3.38T | SEC |
| 2 | Nov 1, 2024 | M&G PLC | 13G/A | 13.2% | 5.20M | SEC |
| 3 | Oct 15, 2024 | Cawood Frank Wayne | 13G | 5.9% | 2.34M | SEC |
| 4 | Feb 13, 2024 | M&G Investment Management Ltd | 13G/A | 13.5% | 5.20M | SEC |
| 5 | Jan 20, 2023 | M&G Investment Management Ltd | 13G/A | 13.9% | 5.20M | SEC |
| 6 | Jan 20, 2023 | M&G Investment Management Ltd | 13G/A | 13.9% | 5.20M | SEC |
| 7 | Oct 7, 2022 | M&G Investment Management Ltd | 13G | 14.0% | 5.20M | SEC |
| 8 | Feb 11, 2022 | Oxford Science Enterprises PLC | 13G | 25.2% | 8.80M | SEC |
| 9 | Jan 19, 2022 | M&G Alternatives Investment Management Ltd | 13G/A | 12.0% | 4.11M | SEC |
| 10 | Nov 5, 2021 | M&G Alternatives Investment Management Ltd | 13G | 12.0% | 4.11M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | M&G PLC | 5.20M | $5.20M |
| 2 | Hsg Holding Ltd | 1.42M | $1.16M |
| 3 | Glr Partners, LLC | 1.24M | $707.5K |
| 4 | Dc Funds, LP | 642.2K | $365.4K |
| 5 | Rangeley Capital, LLC | 159.5K | $90.7K |
| 6 | Renaissance Technologies LLC | 151.0K | $85.9K |
| 7 | Johns Hopkins University | 122.2K | $69.6K |
| 8 | Citadel Advisors LLC | 119.0K | $68.1K |
| 9 | Baird Financial Group, Inc. | 106.0K | $60.3K |
| 10 | Gts Securities LLC | 73.2K | $41.9K |